Adrenocortical SPECT using iodine-131 NP-59

Journal of Nuclear Medicine

Volumn 39, Issue 8 SUPPL., 1998, Pages 1460-1463

  Hwang, Inku ^a   Balingit, Antonio G ^b   Georgitis, William J ^a   Sisson, James C ^a   Shapiro, Brahm ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

B beta iodomethyl 19 norcholesterol; Primary aldosteronism; SPECT

Indexed keywords

6BETA IODOMETHYL 19 NORCHOLEST 5(10) EN 3BETA OL I 131; ALDOSTERONE; DEXAMETHASONE; POTASSIUM; RENIN;

ADRENAL SCINTISCANNING; ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; HUMAN; HYPERTENSION; HYPOKALEMIA; MALE; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADOSTEROL; ADRENAL GLANDS; HUMANS; HYPERALDOSTERONISM; HYPERPLASIA; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031856512     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Velchik MG. Krcssel 1IY, Noel AW, et al. Primary aldosteronism: CT. MRI, scintigraphic corrélation, lmv.il Radio! 1985:20:237-241.
2. Gross MD. Shapiro B. Scintigraphic studies in adrenal hypertension. Semin Nuel Med 1989:19:122-143.
3. Alterman SL. Dominguez C. Lopez-Gome/ A. el al. Primary adrenoeortieal eureinoma causing aldoslcronism. Cancer 1969:24:602 609.
4. Shenker Y. (iross MD. Grekin RJ, et al. The scintigraphic localization of mineralocorticoid-producing adrenal cortical carcinoma. J Endocrinal Invest 1986:9:115-120.
5. Weinberger MH, Grim CE. Hollifielcl JW, et al. Primär)' aldosteronism: diagnosis, localization and treatment. Ann Intern Metl 1979:90:386-395.
6. Gross MD. Valk TW. Swanson DP. et al. The role of pharmacologie manipulation in adrenal cortical scintigraphy. Semin A'iir/ Med 1981:9:128 148.
7. Gross MD. The role of the adrenal gland in hypertension. Urol Radial 19X2:3:233 235.
8. Beienvaltes WH. Lieherman LM. Ansari AN, et al. Visualization of human adrenal glands in vivo by scintillation scanning. JAMA 1971:216:275-277.
9. Sarkar SD. C'ohen EL. Beierwaltes WH. et al. A new and superior adrenal imaging agent. l-131-68-iodomethy!-19-norcholesterol (NP-59): evaluation in humans.J Clin Kmldcrinnl Meiah 1977:45:353-362.
10. Francis 1R, Gross MD. Shapiro B, et al. Integrated imaging of adrenal disease. Radiology 1992;184:1 13.
11. Ikeda DM. Francis 1R. ülazer GM, et al. The detection of adrenal tumors and hyperplasia in patients with primary aldosteronism: comparison of scintigraphy. CT and MR imaging. AJR 1989:153:301-306.
12. Biglieri FG. Sehamberlan M. Slaton PF, et al. The intercurrent hypertension of primary aldosteronism. Ci re Res 1970;27(suppl 1 ):I-lc>5-!-202.
13. Raer F, Sommers SC. Krakoff FR. et al. Pscudoprimary aldosteronism. An entity distinct from true primary aldosteronism. Ci re Res 1970;27(suppl 1 ):I-203-I-216.
14. Gain JP, Tuck ML. Williams GH. et al. The regulation of aldosterone secretion in primary aldosteronism. Am J Med 1972:53:627 637.
15. Gross MD. Shapiro B, Grekin RJ, et al. Scintigraphic localization of adrenal lesions in primary aldosteronism. Am J Vied 1984:77:839- 844.
16. Britton KF, Shapiro B. Hawkins FA. Emission tomography lor adrenal imaging. nel Med Commun 1980:1:37-40.
17. Britton KE, Shapiro B, Fondres S. et al. The tomoscanner Il-clinical results. In: Paras P, Eikman EA, eds. Emission computed tomography: the single photon approach. HHS Publication EDA 81-8177. Rockville. MD: U.S. Department of Health and Human Services: 1981:215 225.